Flumetasone or flumethasone
- Level
- Commodity
- Parent
- 51422300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422370This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28F2O5, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier LR3CD8SX89, chemically known as 6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione but more generally known as flumetasone, which bears U.S. NIH Compound Identifier 16490. European Medicines Agency schedules Flumetasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07698MIG. The term FLUMETASONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules flumetasone in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. FLUMETASONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Same parent
Under 51422300 · 70Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.